Active Clinical Trials
Diabetic Retinopathy and Diabetic Macular Edema
DRCR.net Protocol W:
Intravitreous Anti-VEGF Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
DRCR.net Protocol AC:
Randomized Trial of Intravitreous Aflibercept versus Intravitreous Bevacizumab + Deferred Afliberceptf or Treatment of Central-Involved Diabetic Macular Edema
Status: Actively enrolling
Age-Related Macular Degeneration
Dry Macular Degeneration:
Phase III , Multi-Center, Randomized, Double-Masked, Sham –Controlled study to compare the Efficacy and Safety of Intravitreal APL-2 Therapy with Sham Injections In Patients with Geographic Atrophy secondary to Age-Related Macular Degeneration.
Status: Anticipated start in October, 2018
Wet Macular Degeneration:
GBV-102, long-acting depot therapy for neovascular age-related macular degeneration.
Status: Anticipated start in early 2019